Concha A - Search Results

1

HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.

Torres LM, Cabrera T, Concha A, Oliva MR, Ruiz-Cabello F, Garrido F. Torres LM, et al. Among authors: concha a. Tissue Antigens. 1993 Feb;41(2):65-71. doi: 10.1111/j.1399-0039.1993.tb01981.x. Tissue Antigens. 1993. PMID: 8386400

2

HLA molecules in basal cell carcinoma of the skin.

Cabrera T, Garrido V, Concha A, Martín J, Esquivias J, Oliva MR, Ruiz-Cabello F, Serrano S, Garrido F. Cabrera T, et al. Among authors: concha a. Immunobiology. 1992 Sep;185(5):440-52. doi: 10.1016/s0171-2985(11)80086-0. Immunobiology. 1992. PMID: 1452215

3

Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.

Redondo M, Concha A, Oldiviela R, Cueto A, Gonzalez A, Garrido F, Ruiz-Cabello F. Redondo M, et al. Among authors: concha a. Cancer Res. 1991 Sep 15;51(18):4948-54. Cancer Res. 1991. PMID: 1654207

4

Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.

Redondo M, Ruiz-Cabello F, Concha A, Cabrera T, Pérez-Ayala M, Oliva MR, Garrido F. Redondo M, et al. Among authors: concha a. Cancer Res. 1991 May 1;51(9):2463-8. Cancer Res. 1991. PMID: 1849792

5

Loss of HLA heavy chain and beta 2-microglobulin in HLA negative tumours.

Cabrera T, Concha A, Ruiz-Cabello F, Garrido F. Cabrera T, et al. Among authors: concha a. Scand J Immunol. 1991 Aug;34(2):147-52. doi: 10.1111/j.1365-3083.1991.tb01531.x. Scand J Immunol. 1991. PMID: 1866599

6

Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.

Concha A, Esteban F, Cabrera T, Ruiz-Cabello F, Garrido F. Concha A, et al. Semin Cancer Biol. 1991 Feb;2(1):47-54. Semin Cancer Biol. 1991. PMID: 1912518

7

HLA class I and II expression in rhabdomyosarcomas.

Fernández JE, Concha A, Aránega A, Ruiz-Cabello F, Cabrera T, Garrido F. Fernández JE, et al. Among authors: concha a. Immunobiology. 1991 Aug;182(5):440-8. doi: 10.1016/S0171-2985(11)80208-1. Immunobiology. 1991. PMID: 1916885

8

Can the HLA phenotype be used as a prognostic factor in breast carcinomas?

Concha A, Cabrera T, Ruiz-Cabello F, Garrido F. Concha A, et al. Int J Cancer Suppl. 1991;6:146-54. doi: 10.1002/ijc.2910470726. Int J Cancer Suppl. 1991. PMID: 2066180

9

[Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].

Esteban F, Concha A, Ruiz-Cabello F, Garrido F. Esteban F, et al. Among authors: concha a. Acta Otorrinolaringol Esp. 1990 Sep-Oct;41(5):297-303. Acta Otorrinolaringol Esp. 1990. PMID: 2076309 Spanish.

10

[Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens].

Esteban F, Concha A, Delgado M, Ruiz-Cabello F, Garrido F. Esteban F, et al. Among authors: concha a. Acta Otorrinolaringol Esp. 1990 Nov-Dec;41(6):359-68. Acta Otorrinolaringol Esp. 1990. PMID: 2092725 Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters